BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24359280)

  • 1. Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo.
    Mvumbi DM; Boreux R; Sacheli R; Lelo M; Lengu B; Nani-Tuma S; Melin P; Ntumba K; Lunganza K; DeMol P; Hayette MP
    Malar J; 2013 Dec; 12():459. PubMed ID: 24359280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Likwela JL; De Mol P; Okitolonda EW; Speybroeck N; Mvumbi GL; Hayette MP
    Malar J; 2020 Mar; 19(1):121. PubMed ID: 32197607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.
    Antonia AL; Taylor SM; Janko M; Emch M; Tshefu AK; Meshnick SR
    Am J Trop Med Hyg; 2014 Jun; 90(6):1094-7. PubMed ID: 24732459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population genetic analyses of Plasmodium falciparum chloroquine receptor transporter gene haplotypes reveal the evolutionary history of chloroquine-resistant malaria in India.
    Awasthi G; Prasad GB; Das A
    Int J Parasitol; 2011 Jun; 41(7):705-9. PubMed ID: 21447338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawal.
    Ndiaye M; Faye B; Tine R; Ndiaye JL; Lo A; Abiola A; Dieng Y; Ndiaye D; Hallett R; Alifrangis M; Gaye O
    Am J Trop Med Hyg; 2012 Oct; 87(4):640-645. PubMed ID: 22927495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019.
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Akilimali PZ; Situakibanza HNT; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
    BMC Infect Dis; 2022 Feb; 22(1):145. PubMed ID: 35144535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene.
    Gama BE; Pereira-Carvalho GA; Lutucuta Kosi FJ; Almeida de Oliveira NK; Fortes F; Rosenthal PJ; Daniel-Ribeiro CT; de Fátima Ferreira-da-Cruz M
    Malar J; 2010 Jun; 9():174. PubMed ID: 20565881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019.
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Situakibanza HNT; Umesumbu SE; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
    Malar J; 2021 Mar; 20(1):144. PubMed ID: 33706773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT.
    Dittrich S; Alifrangis M; Stohrer JM; Thongpaseuth V; Vanisaveth V; Phetsouvanh R; Phompida S; Khalil IF; Jelinek T
    Trop Med Int Health; 2005 Dec; 10(12):1267-70. PubMed ID: 16359407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.
    Frank M; Lehners N; Mayengue PI; Gabor J; Dal-Bianco M; Kombila DU; Ngoma GM; Supan C; Lell B; Ntoumi F; Grobusch MP; Dietz K; Kremsner PG
    Malar J; 2011 Oct; 10():304. PubMed ID: 22004584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.
    Keen J; Farcas GA; Zhong K; Yohanna S; Dunne MW; Kain KC
    J Clin Microbiol; 2007 Sep; 45(9):2889-93. PubMed ID: 17609321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia.
    Golassa L; Enweji N; Erko B; Aseffa A; Swedberg G
    Malar J; 2014 Mar; 13():120. PubMed ID: 24674605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt.
    Takahashi N; Tanabe K; Tsukahara T; Dzodzomenyo M; Dysoley L; Khamlome B; Sattabongkot J; Nakamura M; Sakurai M; Kobayashi J; Kaneko A; Endo H; Hombhanje F; Tsuboi T; Mita T
    Malar J; 2012 Mar; 11():92. PubMed ID: 22453078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of malaria and chloroquine resistance in Mizoram, northeastern India, a malaria-endemic region bordering Myanmar.
    Zomuanpuii R; Hmar CL; Lallawmzuala K; Hlimpuia L; Balabaskaran Nina P; Senthil Kumar N
    Malar J; 2020 Feb; 19(1):95. PubMed ID: 32103751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future.
    Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A
    Malar J; 2012 Apr; 11():113. PubMed ID: 22498364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
    Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.
    Koukouikila-Koussounda F; Jeyaraj S; Nguetse CN; Nkonganyi CN; Kokou KC; Etoka-Beka MK; Ntoumi F; Velavan TP
    Malar J; 2017 Apr; 16(1):155. PubMed ID: 28420403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of chloroquine and sequence variation in pfcrt gene among patients with falciparum malaria in central India.
    Bharti PK; Alam MT; Boxer R; Shukla MM; Gautam SP; Sharma YD; Singh N
    Trop Med Int Health; 2010 Jan; 15(1):33-40. PubMed ID: 19912592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India.
    Chatterjee M; Ganguly S; Saha P; Guha SK; Basu N; Bera DK; Maji AK
    Infect Genet Evol; 2016 Oct; 44():281-285. PubMed ID: 27448953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.